drug · small molecule
dalfampridine IR
Phase 2updated 3mo agoby Solaxa Inc🔗 ChEMBL
Phase 2community read0 votes
🐶 often sniffed alongside
top 5Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for multiple sclerosis and 15 investigational indications.
targets
Voltage-gated potassium channel
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 46m ago
Found something off?
comments(0)
5-min edit window · permanent after that